MRAM EVERSPIN TECHNOLOGIES INC.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1438423 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY28.7%
TTM net income YoY-1,636.6%
TTM EPS YoY-1,950.0%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—
Margins
Gross margin52.2%
Operating margin-23.3%
Net margin-14.3%
FCF margin-9.3%
EBITDA margin-19.3%
Returns
ROE-14.8%
ROA-11.6%
ROIC (approx.)-53.1%
Asset turnover0.81x
Leverage & solvency
Liabilities / assets24.9%
Debt / equity0.01x
Current ratio3.31x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.43x
Accruals ratio-16.5%
Payout ratio—
Capex / revenue15.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $55.20M | $50.40M |
| Cost of revenue | $26.96M | $24.28M |
| Gross profit | $28.24M | $26.13M |
| R&D expense | $14.09M | $13.69M |
| SG&A expense | $14.55M | $14.14M |
| Operating income | -$6.51M | -$7.09M |
| Pretax income | -$457,000 | $741,000 |
| Income tax | $129,000 | -$40,000 |
| Net income | -$586,000 | $781,000 |
| EBITDA | -$3.30M | -$5.36M |
| EPS (basic) | -0.03 | 0.04 |
| EPS (diluted) | -0.03 | 0.04 |
| Dividends declared per share | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 22.57M | 22.16M |
| Balance sheet | ||
| Cash & equivalents | $44.45M | $42.10M |
| Receivables | $8.10M | $11.72M |
| Inventory | $10.73M | $9.11M |
| Current assets | $65.16M | $64.20M |
| PP&E, net | $14.14M | $3.22M |
| Intangibles | $1.71M | $3.42M |
| Total assets | $84.61M | $77.79M |
| Current liabilities | $13.45M | $9.91M |
| Short-term debt | $1.77M | $1.77M |
| Long-term debt | $15,000 | $1.78M |
| Total debt | $1.78M | $3.55M |
| Total liabilities | $15.69M | $15.20M |
| Shareholders' equity | $68.92M | $62.59M |
| Net debt | -$42.67M | -$38.54M |
| Shares outstanding | 22.98M | 22.06M |
| Cash flow statement | ||
| Operating cash flow | $9.96M | $7.10M |
| Capital expenditure | $6.84M | $3.05M |
| Free cash flow | $3.12M | $4.05M |
| Investing cash flow | -$8.67M | -$3.06M |
| Financing cash flow | $1.07M | $1.11M |
| Depreciation & amortization | $3.21M | $1.73M |
| Stock-based compensation | $5.78M | $6.71M |
Free plan shows the latest 2 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.